Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV674
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $107,502
Award facts
- Contract value 100% obligated
- $107,501.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $107.5K delivery order to Amerisourcebergen Drug Corp (subsidiary of Cencora, Inc.) on January 20, 2026, for the supply of Dupixent 300 mg/2 mL pens. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The contract will be performed at the company's corporate office in Conshohocken, Pennsylvania, with a completion deadline of January 21, 2026. Amerisourcebergen Drug Corp serves as a critical pharmaceutical distributor for the Defense Logistics Agency's Medical Supply Chain and holds a significant $1 billion indefinite delivery contract with DLA Troop Support Medical (SPE2DX) running through December 2026.
Dupixent is a specialty pharmaceutical used in the treatment of various allergic and inflammatory conditions, including atopic dermatitis, asthma, and chronic rhinosinusitis. This delivery order represents a task order executed under the parent company's comprehensive global pharmaceutical prime vendor contract, which enables Amerisourcebergen to supply an extensive range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs and other federal medical institutions worldwide. The contract demonstrates the company's continued capability to fulfill federal requirements for specialized pharmaceutical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FV674?
SPE2DR26FV674 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FV674 worth?
The government has obligated $107,502 on SPE2DR26FV674.
Is contract SPE2DR26FV674 an order under another contract?
Yes. SPE2DR26FV674 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV674 competed?
The extent of competition for SPE2DR26FV674 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award